Key result
Moderate-to-severe depressive symptoms in patients with heart failure were associated with lower health-related quality of life compared to no depressive symptoms.
Why the study?
The PHQ9 effectively identifies HF patients at risk for lower HRQoL, but the relationships between varying levels of depressive symptomatology and HRQoL, life satisfaction, disease severity, and risk factors remained to be compared.
Are different levels of depressive symptomatology associated with differences in health-related quality of life and life satisfaction in patients with heart failure?
Cross-Sectional (n=221)
Are different levels of depressive symptomatology associated with differences in health-related quality of life and life satisfaction in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Even mild, clinically non-significant levels of depressive symptoms in heart failure patients are associated with significantly impaired psychosocial status and lower life satisfaction.
Background: The Patient Health Questionnaire 9 (PHQ9) has been recognized as an effective tool for identification of patients with heart failure (HF) at risk for lower health-related quality of life (HRQoL). We aimed to compare HRQoL levels, overall satisfaction with health and life, disease severity variables, sociodemographic variables and behavioural risk factors between patients with HF with different levels of depressive symptomatology. Methods: In a >55 years-old general population cross-sectional HF prevalence study, 1851 subjects were screened and those with NTproBNP ≥125 pg/mL (n=930) underwent detailed diagnostic visit to confirm or rule out HF as per 2016 European Society of Cardiology guidelines. HRQoL (the ShortForm 12 Health Survey, SF12; EQ5D3L), depressive symptoms (Patient Health Questionnaire, PHQ9) and satisfaction with life (Satisfaction With Life Scale, SWLS) were also assessed. Patient with HF (75±8 years, 54 % male, New York Heart Association (NYHA) functional class IIII, with mean left ventricular ejection fraction (LVEF) 56±13) were divided into three groups based on the severity of depressive symptomatology as per PHQ9 score (none: score 04, mild: score 59, and moderate-to-severe: score 1027). Multiple group comparisons and pairwise post hoc analyses were performed. Results: Results indicated significant between group differences in NYHA status (p<0.001), number of comorbidities (p=0.006), functional capacity (p=0.01), as well as HRQoL variables (p=0.05 to 0.001) and SWLS score (p<0.05), with nondepressed group generally showing better physical and subjective indicators of health and wellbeing compared with the mild and moderate-to-severe group. Conclusions: Results indicate that even patients with HF with clinically non-significant levels of depressive symptomatology show significantly impaired psychosocial status (diminished HRQoL, lower life satisfaction).
No takes yet. Share an insight, caveat, or question.
Kobe et al. (2024) conducted a cross-sectional in Heart failure (n=221). Depressive symptomatology vs. No depressive symptomatology was evaluated on Health-related quality of life (EQ-5D-3L index score) (p=<0.001). Moderate-to-severe depressive symptoms in patients with heart failure were associated with lower health-related quality of life compared to no depressive symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: